Cart
sales@molnova.com
Home -
Products -
Angiogenesis -
CDK -
Benzo[b]thiophene-2-sulfonamide, N-[3-(aminomethyl)phenyl]-5-chloro-3-methyl-
Benzo[b]thiophene-2-sulfonamide, N-[3-(aminomethyl)phenyl]-5-chloro-3-methyl-
CAS No. 2428737-43-1
Benzo[b]thiophene-2-sulfonamide, N-[3-(aminomethyl)phenyl]-5-chloro-3-methyl-( —— )
Catalog No. M28870 CAS No. 2428737-43-1
Benzo[b]thiophene-2-sulfonamide, N-[3-(aminomethyl)phenyl]-5-chloro-3-methyl- directly inhibits InhA and does not require activation by the catalase peroxidase KatG.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 198 | In Stock |
|
| 5MG | 192 | In Stock |
|
| 10MG | 283 | In Stock |
|
| 25MG | 452 | In Stock |
|
| 50MG | 631 | In Stock |
|
| 100MG | 848 | In Stock |
|
| 200MG | 1107 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBenzo[b]thiophene-2-sulfonamide, N-[3-(aminomethyl)phenyl]-5-chloro-3-methyl-
-
NoteResearch use only, not for human use.
-
Brief DescriptionBenzo[b]thiophene-2-sulfonamide, N-[3-(aminomethyl)phenyl]-5-chloro-3-methyl- directly inhibits InhA and does not require activation by the catalase peroxidase KatG.
-
DescriptionBenzo[b]thiophene-2-sulfonamide, N-[3-(aminomethyl)phenyl]-5-chloro-3-methyl- directly inhibits InhA and does not require activation by the catalase peroxidase KatG.
-
In VitroInhA-IN-2 (Compound 23) (200 μM, 48h) inhibits mycolic acid synthesis (33% growth inhibition) in M. tuberculosis H37Ra.
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCytochrome P450
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2428737-43-1
-
Formula Weight366.89
-
Molecular FormulaC16H15ClN2O2S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc(c(cc(cc1)Cl)c1s1)c1S(Nc1cc(CN)ccc1)(=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kasem Nithipatikom, et al. Inhibition of carcinoma cell motility by epoxyeicosatrienoic acid (EET) antagonists. Cancer Sci. 2010 Dec;101(12):2629-36.
molnova catalog
related products
-
Ibulocydine
Ibulocydine is the prodrug of CDK inhibitor BMK-Y101, inhibits CDK7 and CDK9 with IC50 of 530 nM and 85 nM in kinase assays, respectively.
-
BS-181 hydrochloride
BS-181 is a potent, selective CDK7 inhibitor with IC50 of 21 nM.
-
CDK4-IN-1
CDK4 inhibitor is a novel and specific CDK4/Cyclin D1 inhibitor with an IC50 of 10 nM.
